methyl (1R,3R)-1-(1,3-benzodioxol-5-yl)-9-methyl-1,2,3,4-tetrahydropyrido[3,4-b]indole-3-carboxylate

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 哈马拉生物碱
• 英文名称: methyl (1R,3R)-1-(1,3-benzodioxol-5-yl)-9-methyl-1,2,3,4-tetrahydropyrido[3,4-b]indole-3-carboxylate
• 化学式: C₂₁H₂₀N₂O₄
• 分子量: 364.401
• InChiKey: LFOACEVFSAJGLZ-DNVCBOLYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  27
• 可旋转键数：
  3
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  61.7
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  methyl (1R,3R)-1-(1,3-benzodioxol-5-yl)-9-methyl-1,2,3,4-tetrahydropyrido[3,4-b]indole-3-carboxylate 在 三乙胺 作用下， 以 乙醇 、 氯仿 为溶剂， 生成 (6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-[(R)-1-benzylpyrrolidin-3-yl]-7-methyl-2,3,6,7,12,12a-hexahydropyrazino-[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
  参考文献：
  名称：

  Drug to Genome to Drug: Discovery of New Antiplasmodial Compounds

  摘要：

  The dominant strategy for discovery of new antimalarial drugs relies on cell-free assays on specific biochemical pathways of Plasmodium falciparum . However, it appears that screening directly on the parasite is a more rewarding approach. The "drug to genome to drug" approach consists of testing a small set of structural analogues of a drug acting on human proteins that have plasmodial orthologues. Both man and plasmodium possess cyclic nucleotide phosphodiesterases (PDEs) that are key players of cell homeostasis. We synthesized and tested 40 analogues of tadalafil, a human PDE5 inhibitor, on P. falciparum in culture and obtained potent inhibitors of parasite growth. We discuss the structure-activity relationships, which support the hypothesis that our compounds kill the parasite via inhibition of plasmodial PDE activity. We also prove that antiplasmodial derivatives inhibit the hydrolysis of cyclic nucleotides of the parasite, validating the cAMP/cGMP pathways as therapeutic targets against Plasmodium falciparum .

  DOI：

  10.1021/jm1014617
• 作为产物：
  描述：

  1-甲基吲哚-3-甲醛 在 吡啶 、 5% Pd/C 、 氢气 、 四氯化钛 、 苯甲酸 作用下， 以 四氢呋喃 、 乙腈 为溶剂， 20.0 ℃ 、500.01 kPa 条件下， 反应 60.0h， 生成 methyl (1R,3R)-1-(1,3-benzodioxol-5-yl)-9-methyl-1,2,3,4-tetrahydropyrido[3,4-b]indole-3-carboxylate
  参考文献：
  名称：

  使用苊并咪唑亚基连接的恶唑啉环钯合成 3-甲基吲哚的通用方案

  摘要：

  通过使用 1,3-双(2,6-二异丙基苯基)苊并咪唑-2-亚基 (AnIPr) 连接，开发了一种从无活性的邻二卤代芳烃和N-烯丙胺合成N-取代的 3-甲基吲哚的有效催化策略恶唑啉环钯。它实现了非常广泛的底物范围，可以耐受不同的官能团、电子特性和空间体积，并以良好到优异的产率提供所需的产品。重要的是，它显示出高产率合成多种生物活性化合物和天然产物关键中间体的巨大潜力。

  DOI：

  10.1021/acs.orglett.3c03438

文献信息

• PYRAZINO[1',2':1,6]-PYRIDO[3,4-B] INDOLE-1,4-DIONE DERIVATIVES
  申请人：Lilly Icos LLC

  公开号：EP1392688B1

  公开（公告）日：2008-06-04
• Drug to Genome to Drug: Discovery of New Antiplasmodial Compounds
  作者：Terence B. Beghyn、Julie Charton、Florence Leroux、Guillaume Laconde、Arnaud Bourin、Paul Cos、Louis Maes、Benoit Deprez

  DOI：10.1021/jm1014617

  日期：2011.5.12

  The dominant strategy for discovery of new antimalarial drugs relies on cell-free assays on specific biochemical pathways of Plasmodium falciparum . However, it appears that screening directly on the parasite is a more rewarding approach. The "drug to genome to drug" approach consists of testing a small set of structural analogues of a drug acting on human proteins that have plasmodial orthologues. Both man and plasmodium possess cyclic nucleotide phosphodiesterases (PDEs) that are key players of cell homeostasis. We synthesized and tested 40 analogues of tadalafil, a human PDE5 inhibitor, on P. falciparum in culture and obtained potent inhibitors of parasite growth. We discuss the structure-activity relationships, which support the hypothesis that our compounds kill the parasite via inhibition of plasmodial PDE activity. We also prove that antiplasmodial derivatives inhibit the hydrolysis of cyclic nucleotides of the parasite, validating the cAMP/cGMP pathways as therapeutic targets against Plasmodium falciparum .
• A General Protocol toward Synthesis of 3-Methylindoles Using Acenaphthoimidazolyidene-Ligated Oxazoline Palladacycle
  作者：Ruoqian Fan、Haili Wen、Zhen Chen、Yuanzhi Xia、Weiwei Fang

  DOI：10.1021/acs.orglett.3c03438

  日期：2024.1.12

  An efficient catalytic strategy toward the synthesis of N-substituted 3-methylindoles from inactive o-dihaloarenes and N-allylamines was developed by using a 1,3-bis(2,6-diisopropylphenyl)acenaphthoimidazol-2-ylidene (AnIPr)-ligated oxazoline palladacycle. It enabled a very broad substrate scope tolerating different functional groups, electronic properties, and steric bulkiness and afforded desired

  通过使用 1,3-双(2,6-二异丙基苯基)苊并咪唑-2-亚基 (AnIPr) 连接，开发了一种从无活性的邻二卤代芳烃和N-烯丙胺合成N-取代的 3-甲基吲哚的有效催化策略恶唑啉环钯。它实现了非常广泛的底物范围，可以耐受不同的官能团、电子特性和空间体积，并以良好到优异的产率提供所需的产品。重要的是，它显示出高产率合成多种生物活性化合物和天然产物关键中间体的巨大潜力。